As the largest payer of substance use disorder services in the United States, Medicaid plays a central role in state efforts to address the opioid epidemic. In addition to increasing access to addiction treatment services through the expansion of Medicaid under the Affordable Care Act (ACA), states are expanding Medicaid addiction treatment services, increasing provider reimbursements, restricting opioid prescribing, and implementing delivery system reforms to improve the quality of treatment services. While many states have been tracking progress and challenges in these efforts, uniqueness of state systems can make it difficult to compare or benchmark across states. This brief draws on analyses provided by the Medicaid Outcomes Distributed Research Network (MODRN), a collaborative effort to analyze data across multiple states to facilitate learning among Medicaid agencies. It profiles the opioid epidemic among the Medicaid population in six states participating in MODRN that also have been hard hit by the opioid epidemic: Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and West Virginia. The brief also draws on interviews with officials from the state Medicaid and other health agencies.
- view as grid
- view as list
This data note describes uninsured nonelderly adults with opioid use disorder, including their demographic characteristics, health status, and access to treatment.
This brief describes nonelderly adults with opioid use disorder, including their demographic characteristics and insurance status, and compares utilization of treatment services among those with Medicaid to those with other types of coverage. It also describes Medicaid financing for opioid treatment and the ways in which Medicaid promotes access to treatment for enrollees with OUD.
This analysis provides national estimates of insurance coverage among people with HIV and finds about 1 in 10 are uninsured, similar to the share among the general population following the ACA’s coverage expansions. Medicaid is the single largest source of coverage for people with HIV due to the ACA’s Medicaid expansion. The analysis also looks at access to Ryan White program services, and the impact of coverage and the Ryan White program on people with HIV’s ability to achieve sustained viral suppression.
During this year’s State of the Union address, President Trump announced a new effort “to eliminate the HIV epidemic in the United States within 10 years,” drawing national attention to the domestic epidemic and the promise of new prevention and treatment options that greatly reduce the risk of HIV transmission.…
This fact sheet provides an overview of the Ryan White Program, the largest HIV-specific federal grant program in the United States.
This fact sheet provides current information about state AIDS Drug Assistance Programs (ADAPs), which provide HIV medications to low-income people with HIV/AIDS who have limited or no prescription drug coverage.
On August 3, the Kaiser Family Foundation and the Center for Strategic and International Studies (CSIS) hosted a briefing to assess the major outcomes of the 2016 International AIDS Conference (AIDS 2016), held from July 18-22 in Durban, South Africa. The discussion touched on the latest scientific advancements, the current funding climate…
The Kaiser Family Foundation held an interactive web briefing on Tuesday, June 21 to discuss key issues to be addressed at the upcoming International AIDS Conference on July 18-22. The conference will convene in Durban, South Africa, 16 years after it was first held there. The world has seen dramatic progress in…